Techno Trends
TechnoTrends provide comprehensive coverage of the innovations and inventions in pharma products and pharma technologies across the world. The up-to-date listing of latest pharmaceutical product news and technology trends in the global pharma industry, keeps you abreast with all the latest pharmaceutical innovations happening world over.
Breakthrough Therapy Lenvima/Keytruda Combo Treats Patients with Advanced Kidney Cancer
Eisai’s multiple receptor tyrosine kinase inhibitor lenvatinib mesylate (Lenvima) in combination with Merck’s anti-programmed death-1 therapy pembrolizumab (Keytruda) received FDA’s breakthrough therapy designation for treatment of patients with advanced kidney cancer.
This is the second breakthrough therapy designation for lenvatinib and the 12th granted to pembrolizumab.
Lenvima/Keytrud
Cipher Pharmaceuticals Launches a Novel Bactericidal Topical Antibiotic Cream in Canada
Cipher Pharmaceuticals Inc announced the Canadian launch of OZANEX™ (ozenoxacin cream, 1%), a novel bactericidal topical antibiotic cream indicated for the treatment of impetigo in patients aged 2 months and older.
OZANEX can be used to cure one of the most common and contagious bacterial skin infections. It can be utilised as a new and important treatment alternative for skin infections.
Roche’s Balovaptan Gets FDA’s Breakthrough Therapy Designation
Roche announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for its investigational oral medicine Balovaptan.
It is a vasopressin 1a (V1a) receptor antagonist for individuals with Autism Spectrum Disorder (ASD).
The V1a receptor has a role in mediating and modulating key social behaviours associated with individuals with the condition.
New Diabetes Drugs Sensitise Cancer cells to chemotherapy agents
Scientists at Dana-Farber Cancer Institute have shown that experimental diabetes drugs can make cancer cells more defenseless to traditional chemotherapy agents and further said such combinations should be explored to potentially improve outcomes for cancer patients.
They demonstrated in cancer cell lines and animal models that the research compounds - similar to common anti-diabetic agents known as thiazolidinediones (TZDs) - sensit
A New Nanomedicine Prevents the Development of Pancreatic Cancer in Mice
A new Tel Aviv University study pinpoints the inverse correlation between a known oncogene; a gene that promotes the development of cancer and the expression of oncosuppressor microRNA as the reason for extended pancreatic cancer survival.
The Scientists examined pancreatic cancer cells and discovered an inverse correlation between the signatures of miR-34a, a tumor suppressant, and PLK1, a known oncogene.
A New Sophisticated Microscope gives a boost to Optogenetic Studies
Scientists from Harvard, report the development of a new microscope that greatly improves researchers’ ability to study how neurological disorders such as epilepsy and Alzheimer's disease affect neuronal communication.
The microscope is optimised to perform studies using optogenetic techniques that use light to control and image neurons genetically modified with light-sensitive proteins.
First Digital Pill Tracks Patients Medication
Abilify MyCite, the first digital pill, with a sensor digitally tracks if patients have taken their medication. Abilify MyCite also gets an approval from the US Food and Drug Administration (FDA).
This first digital pill is fitted with a digital ingestion tracking system and has an ingestible sensor embedded in the pill that records that the medication was taken.
The Abilify MyCite featur
First-of-its Kind Gene Therapy Could Treat Inherited Blindness
A new gene therapy might be able to recover vision lost in inherited retinal disease patients.
This treatment could pave the way for treating inherited retinal diseases and more common loss of vision due to age degeneration (Unsplash/Vanessa Bumbeers).
Leber Congenital Amaurosis (LCA) patients were capable to see well enough to navigate a maze created for trials, after receiving an invest
Merck Announces First-of-its Kind Filters for CHO & Downstream Filtration Applications
Merck announced Millistak+® HC Pro, the first of its kind high capacity, fully synthetic depth filters for non-treated Chinese Hamster Ovary (CHO) harvest clarification and downstream filtration applications.
Millistak+® HC Pro filter media provides a cleaner and more consistent depth filtration process compared with traditional diatomaceous earth (DE) and cellulose-based filtration processes.
The Millistak+® HC Pro portfol
Pfizer Launches First-of-its Kind Innovative Technologies for Hemophilia Patients
Pfizer announced the launch of Hemocraft™ a modification of the popular video game Minecraft®, and the HemMobile® Striiv® Wearable, a custom wristband. It helps people who suffer with hemophilia with better approaches and activity tracking in the US.
Hemocraft helps younger individuals with hemophilia, 8-16 years of age, to learn the importance of integrating treatment into their routine in an educational and fun gaming environment.<
